Gene-environment Interactions and Brain Functional Connectivity in Attention Deficit Hyperactivity Disorder
NCT01912352 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 83
Last updated 2014-12-04
Summary
The aims of the current study are to examine gene-environment interactions associated with norepinephrine (NE) system genes (ADRA2A, SLC6A2) in ADHD, and to evaluate whether genetic changes in norepinephrine pathway are associated with differences in functional connectivity of white matter fiber tracts, as measured by diffusion tensor imaging (DTI). Furthermore, this study aims to examine neurobiological markers, such as intermediate neuroimaging phenotypes or neuropsychological endophenotypes associated with the pathophysiology of ADHD. Through evaluating drug responses and side effects with the associated measures of clinical, neuropsychological and neuroimaging characteristics, investigators would like to investigate predictors of treatment response associated with NE system genes in ADHD.
Conditions
- Attention Deficit Hyperactivity Disorder
Interventions
- DRUG
-
Methylphenidate
Sponsors & Collaborators
-
Korea Research Foundation
collaborator OTHER -
Seoul National University
lead OTHER
Principal Investigators
-
Jae-Won Kim, MD., PhD. · Seoul National University and Seoul National University Hospital
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2013-04-30
- Completion
- 2013-04-30
More Related Trials
-
Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD
NCT02430896 ·Status: UNKNOWN
-
Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD)
NCT00757029 ·Status: COMPLETED ·Phase: PHASE4
-
Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers
NCT02623114 ·Status: UNKNOWN ·Phase: PHASE4
-
The Association Between Executive Functions and Candidate Genes of Dopaminergic and Noradrenergic Systems in Attention Deficit Hyperactivity Disorder (ADHD)
NCT01052753 ·Status: COMPLETED
-
Genetic Modulation of Working Memory in Attention Deficit Hyperactivity Disorder (ADHD)
NCT01351272 ·Status: COMPLETED ·Phase: PHASE3
-
Structural and Functional Connectivity of Frontostriatal and Frontoparietal Networks as Endophenotypes of ADHD
NCT01682915 ·Status: COMPLETED
-
Study of Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic Stimulation
NCT00001915 ·Status: COMPLETED
-
Impact of Stimulants and In-Scanner Motion on Attentive Task Performance in ADHD (ADHD_NFB)
NCT06779825 ·Status: NOT_YET_RECRUITING
-
Disturbed Structural Connectivity of Frontostriatal and Frontoparietal Networks in Adults With ADHD
NCT02232464 ·Status: COMPLETED
-
Psychostimulants Effects on Brain Functional Connectivity in Youth With Attention Deficit Hyperactivity Disorder
NCT02318017 ·Status: UNKNOWN ·Phase: NA
-
Neuromodulation of Executive Function in the ADHD Brain
NCT04175028 ·Status: COMPLETED ·Phase: NA
-
Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD)
NCT03709940 ·Status: COMPLETED ·Phase: NA
-
Effect of Methylphenidate on Connectivity
NCT01764672 ·Status: WITHDRAWN ·Phase: PHASE4
-
Validity of Neurocognitive Assessment Methods in Childhood ADHD
NCT04201509 ·Status: COMPLETED
-
Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT01238822 ·Status: COMPLETED ·Phase: PHASE4
-
Identify Peripheral Biomarkers of Symptomatology, Neurocognitive Functions, and Medication Response in ADHD
NCT02074228 ·Status: UNKNOWN ·Phase: PHASE4
-
The Role of Adverse Environment Factors, Family Functioning and Parental Psychopathology in the Response to Treatment With Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder
NCT00773916 ·Status: COMPLETED ·Phase: PHASE4
-
Attention-Deficit/Hyperactivity Disorder (ADHD) Brain Activity Changes to Psychostimulants
NCT01310439 ·Status: COMPLETED
-
Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD
NCT01709695 ·Status: COMPLETED ·Phase: PHASE4
-
Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning
NCT00143832 ·Status: UNKNOWN
-
Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD
NCT04781972 ·Status: RECRUITING ·Phase: PHASE4
-
Genetic Polymorphism and OROS-Methylphenidate Treatment in Attention Deficit Hyperactivity Disorder(ADHD)
NCT00842127 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Transcranial Direct Current Stimulation (tDCS) in Patients With Attention Deficit Hyperactivity Disorder (ADHD)
NCT02580890 ·Status: COMPLETED ·Phase: NA
-
Brain Activity Associated With Inhibition of Action in Attention-deficit
NCT04768556 ·Status: COMPLETED ·Phase: NA
-
The Relationship Between CES1 Genotype and Methylphenidate Response in Children With ADHD - INDICES Work Package 6
NCT04366609 ·Status: COMPLETED